Rational design and synthesis of a novel, selective class of thrombin inhibitors: P 1-argininal derivatives incorporating P 3 P 4 quaternary lactam dipeptide …

JE Semple, NK Minami, SY Tamura, TK Brunck…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 18 p. 2421 - 2426

Full Text: HTML

Citation Number: 21

Abstract

... JavaScript is disabled on your browser. Please enable JavaScript to use all the features on this page. Bioorganic & Medicinal Chemistry Letters. Volume 7, Issue 18, 23 September 1997, Pages 2421–2426. ... Department of Medicinal Chemistry, Corvas International, Inc. ...

Related Articles:

Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam …

[Semple; Rowley; Brunck; Ha-Uong; Minami; Owens; Tamura; Goldman; Siev; Ardecky; Carpenter; Ge; Richard; Nolan; Hakanson; Tulinsky; Nutt; Ripka Journal of Medicinal Chemistry, 1996 , vol. 39, # 23 p. 4531 - 4536]

Protected lactam-bridged dipeptides for use as conformational constraints in peptides

[Freidinger, Roger M.; Perlow, Debra Schwenk; Veber, Daniel F. Journal of Organic Chemistry, 1982 , vol. 47, # 1 p. 104 - 109]

Design, synthesis, and structure–Activity relationships of unsubstituted piperazinone-Based transition state factor Xa inhibitors

[Bioorganic and Medicinal Chemistry Letters, , vol. 13, # 4 p. 723 - 728]

Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam …

[Journal of Medicinal Chemistry, , vol. 39, # 23 p. 4531 - 4536]

Design, Synthesis, and Evolution of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors: P1-Argininal Derivatives Incorporating P3-P4 Lactam …

[Journal of Medicinal Chemistry, , vol. 39, # 23 p. 4531 - 4536]

More Articles...